ClinicalTrials.gg
Sign In

Raynaud Disease clinical trials

The registry lists 81 studies for Raynaud Disease across more than 10 countries. 8 are recruiting or about to start. 59 of them are mainly about Raynaud Disease (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-09.

Get an email when these change. Save the Raynaud Disease studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
53
Status unknown
10
Terminated
7
Recruiting
5
Not yet recruiting
3
Withdrawn
3

Phase

Phase 2
23
Phase 3
20
Phase 4
6
Phase 1
3
Early Phase 1
2

Where

United States
33
France
12
United Kingdom
10
Germany
8
Canada
6
Korea, Republic of
3

Who runs them

MediQuest Therapeutics (8) · University Hospital, Grenoble (6) · London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's (3) · Emory University (2) · Johns Hopkins University (2) · Brigham and Women's Hospital (2) · Seoul National University Hospital (2) · Sanjay Gandhi Postgraduate Institute of Medical Sciences (2)

What is being tested here

Drugs under test in Raynaud Disease studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Treprostinil203
Botulinum toxin type A136
Oxygen101
Nitroglycerin014
Onabotulinum toxin A013
Tadalafil013
Nifedipine012
Sildenafil022
Cilostazol002
Botulinum Toxins001

Drug classes tested here PDE5 inhibitors 6

Coming up

1phase 3 study under way
1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Who these studies take

Of the 5 Raynaud Disease studies recruiting now, 4 (80%) set no upper age limit and 1 (20%) stop at 75 or younger. 1 (20%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (20%) take healthy volunteers.

Recruiting studies that take each age, of 5
AgeWomenMen
100 (0%)0 (0%)
185 (100%)5 (100%)
305 (100%)5 (100%)
405 (100%)5 (100%)
505 (100%)5 (100%)
655 (100%)5 (100%)
755 (100%)5 (100%)
854 (80%)4 (80%)

Across all 81 studies, recruiting or not: 42% stop at 75 or younger and 17% at 65; 10% take children; 2% are for women only and 0% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 81. Browse all 81 → or search them.